Brind.

Stifel reiterated a Buy rating and target price for Spyre Therapeutics, while Deutsche Bank lowered targets following company results.

1 report, 1 independent Updated Aug 31

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Stifel Deutsche Bank

Keep exploring

The entities involved

Stifel
American investment bank
- Stifel established its firm in St. Louis.Wed 13:17
Deutsche Bank
German global banking and financial services company
- Deutsche Bank upgraded RS Group stock to buy, citing expectations that the end of the Iran war would boost cyclicals.Thu 13:22
- An individual has connections to Deutsche Bank in Baltimore and attended Florida Gulf Coast University and Florida SouthWestern State College.Wed 19:10

Coverage

Newest first; wire copies grouped

Aug 31yahoo.com